Abstract:Objective To examine the kinetics of plasma S100A12 and soluble receptor for advanced glycation end products (sRAGE) in infants and young children undergoing cardiopulmonary bypass ( CPB),and to investigate whether they could protective the occurrence of noninfectious pulmonary complication (NPC) after cardiac surgery.Methods This was a case-control study.The subjects included all children aged ＜3 years old who underwent cardiac surgery with CPB during the period from June 1st to July 31st 2011.The patient who showed pulmonary inflammation or had abnormal liver or renal function before surgery was excluded.The remain patients were divided into 2 groups according to whether they had developed NPC postoperatively.Twenty patients were grouped into NPC because they developed the complications of pleural effusion,chylothorax,partial lung collapse,pulmonary hypertensive crisis,airway disorders,pneumothorax,pneumomediastinum,or phrenic nerve palsy.Forty patients were categorized into the no-NPC group.Plasma concentrations of S100A12 and sRAGE were measured using ELISA at baseline,before CPB,immediately after CPB,1 h,12 h and 24 h after operation.Differences concentrations between two groups were analyzed with t test.A stepwise logistic regression analysis was used to indentify the independent risk factor for NPC.A P value ＜0.05 was considered statistically significant.Results Plasma levels of S100A12 and sRAGE dramatically increased immediately after CPB ( P ＜ 0.01 ).The levels of sRAGE dropped to lower than baseline level (P ＜0.05),while S100A12 was still at high level 24h after operation (P ＜0.01 ).Levels of S100A12 and sRAGE immediately after CPB in NPC group were significantly higher than the no-NPC group (P ＜ 0.05).Twenty-four hours after operation,levels of S100A12 were still higher in NPC group than no-NPC (P ＜ 0.01 ),while levels of sRAGE were similar in the two groups ( P ＞ 0.05 ).In the stepwise logistic regression analysis,plasma S100A12 level immediately after CPB remained as a independently predictor for postoperative NPC (OR =1.042,95％ CI:1.010 ～ 1.076,P =0.011 ).Levels of S100A12 immediately after CPB were positively associated with mechanical ventilation time ( r =0.47,P ＜ 0.01 ),duration of surgical Intensive Care Unit ( r =0.407,P =0.002) and hospital stay ( r =0.421,P =0.01 ).Conclusions Plasma levels of S100A12 and sRAGE were significantly increased immediately after CPB and the elevated plasma S100A12 immediately after CPB served as an early reliable biomarker of the occurrence and the prognosis of NPC after CPB in infants and young children.

Variations of placental growth factor and its receptor Fit-1 before and after cardiopulmonary bypass

Changes in transforming growth factor-beta mRNA expressionin the lung in a dog model of cardiopulmonary bypass-induced acute lung injury

Effect of ulinastatin on expression of S100β protein and TNF-α in patients undergoing open-heart surgery with cardiopulmonary bypass

Changes in Plasma Granule Membrane Protein-140 in Patients with Cardiopulmonary Resuscitation

Changes in Phospholipase D Activity of Leukocytes During Human Systemic Inflammatory Response Syndrome Induced by Cardiopulmonary Bypass.

[Perioperative changes in plasma endothelin and calcitonin gene-related peptide in congenital heart disease with pulmonary hypertension].

Detection of Intercellular Adhesion Molecule-1 during Pediatric Cardiopulmonary Bypass

Changes of Plasma Soluble Fas and Soluble Fas Ligand in Patients Undergoing Coronary Artery Bypass Surgery with or Without Cardiopulmonary Bypass

Investigation of the Underlying Hub Genes and Mechanisms of Reperfusion Injury in Patients Undergoing Coronary Artery Bypass Graft Surgery by Integrated Bioinformatic Analyses.

Changes of Plasma Caicitonin Gene-Related Peptide in Perioperative Period of Cardiopulmonary Bypass

Effects of Cardiopulmonary Bypass on Plasma Levels of Procalcitonin and Cytokines

Studying the Association of Plasma S100a12 and Noninfectious Pulmonary Complication in Infants and Young Children Following Cardiopulmonary Bypass

Expression of Adhesion Molecule of Myocardial Tissue During Cardiopulmonary Bypass and Influence of Aprotinin

Studying the association of plasma S100A12 and noninfectious pulmonary complication in infants and young children following cardiopulmonary bypass (HUM1P.305)

Changes of Plasma P-selectin、 Thrombomodulin、 Plasminogen Activator Inhibitor-1 of Coronary Artery Disease Patients Before and after PTCA

The effect of cardiopulmonary bypass on the activation of peripheral T lymphocytes in children under open - heart operation

Changes of Serum Hepatocyte Growth Factor Before and after Percutaneous Coronary Intervention in Patients with Unstable Angina Pectoris and Significance There

Plasma Levels of Growth Differentiation Factor-15 Are Associated with Myocardial Injury in Patients Undergoing Off-Pump Coronary Artery Bypass Grafting

[Effect of Cardiopulmonary Bypass on CD11/CD18 Expression of Neutrophils in Children Undergoing Cardiac Surgery].

The effect of cardiopulmonary bypass on monocyte HLA-DR expression

Expression of Placental Vascular Growth Factor in Pregnancy-Induced Hypertension